跳至主要内容
临床试验/NCT00900016
NCT00900016已完成不适用

Pharmacodynamic Study of Fibroblast Activity Protein in Patients With Localized Pancreas Cancer Undergoing Surgical Resection

Fox Chase Cancer Center1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2007年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
Independence of tumor fibroblast activation protein (FAP) activity and Met-α2-antiplasmin expression

研究概览

简要总结

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is assessing fibroblast activity in patients with localized pancreatic cancer undergoing surgery.

详细描述

OBJECTIVES:

Primary

  • To assess the degree of fibroblast activation protein (FAP) enzymatic activity at the tumor site in patients with localized pancreatic cancer.

Secondary

  • To explore correlations between tumor stromal FAP enzymatic activity and stromal α_2-antiplasmin levels.
  • To explore correlations between tumor FAP enzymatic activity and plasma dipeptidyl peptidase and plasma α_2-antiplasmin converting enzyme activity as potential surrogates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Independence of tumor fibroblast activation protein (FAP) activity and Met-α2-antiplasmin expression

时间窗: Within 28 days for prior to surgery and at 3 month intervals for up to 2 years or recurrence

次要结局

  • Potential plasma surrogates of plasma dipeptidyl peptidase activity and plasma antiplasmin converting enzyme(Within 28 days for prior to surgery and at 3 month intervals for up to 2 years or recurrence)
  • Feasibility of exploiting the circulatory compartment to identify surrogates of tumor FAP(Within 28 days for prior to surgery and at 3 month intervals for up to 2 years or recurrence)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验